A -year-old woman comes to the clinic complaining of intermittent, crampy abdominal pain, bloating, and loose, foul-smelling stools for the past months. She also reports progressive fatigue and an unintentional weight loss of kg ( lbs) during this time. Her past medical history is significant for autoimmune thyroiditis, for which she takes levothyroxine. Vital signs are within normal limits. Physical examination reveals mild abdominal distension without tenderness. Laboratory studies show a hemoglobin concentration of g/dL and a mean corpuscular volume of fL.
Which of the following is the most appropriate next step in laboratory evaluation?
- AMeasurement of deamidated gliadin peptide IgG antibodies
- BFecal calprotectin assay
- Measurement of tissue transglutaminase IgA antibodies and total serum IgA levelsAnswer
- DHLA-DQ2 and HLA-DQ8 genotyping
- EHemoglobin electrophoresis
Answer
Measurement of tissue transglutaminase IgA antibodies and total serum IgA levels is the most appropriate initial diagnostic laboratory test.
The correct answer is the measurement of tissue transglutaminase IgA antibodies and total serum IgA levels. This patient presents with chronic diarrhea, bloating, weight loss, and microcytic anemia, which forms a classic presentation of malabsorption. Given her history of autoimmune thyroiditis, celiac disease is the most likely diagnosis. The initial laboratory evaluation for suspected celiac disease is serologic screening with tissue transglutaminase (tTG) IgA antibodies. Because celiac disease is highly associated with selective IgA deficiency, a total serum IgA level must be measured concurrently. If the patient is IgA deficient, the tTG-IgA test could yield a false-negative result, and IgG-based testing would then be required.
Step-by-Step Solution
Key Concept
The initial laboratory evaluation for suspected celiac disease involves measuring tissue transglutaminase (tTG) IgA antibodies alongside a total serum IgA level to account for the possibility of concurrent selective IgA deficiency.